Sangamo Therapeutics(SGMO) - 2024 Q3 - Earnings Call Transcript

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Louise Wilkie - Vice President, Investor Relations and Corporate Communications Sandy Macrae - Chief Executive Officer Nathalie Dubois-Stringfellow - Chief Development Officer Prathyusha Duraibabu - Senior Vice President, Chief Financial Officer & Principal Accounting Officer Conference Call Participants Gena Wang - Barclays Maury Raycroft - Jefferies Luca Issi - RBC Capital Markets Ri ...